Key result
Remote HRV biofeedback improves depressive symptoms and HRV compared to controls in meta-analysis.
Why the study?
Heart rate variability biofeedback has shown benefits for health, but the methodology and efficacy of remote interventions for mental health symptoms and heart rate variability needed evaluation.
Does remote heart rate variability biofeedback improve mental health symptoms and heart rate variability across different populations?
Meta-Analysis (n=1,352)
Does remote heart rate variability biofeedback improve mental health symptoms and heart rate variability across different populations?
Standardized Mean Difference: -0.41 (95% CI -0.772–-0.049)
p-value: p=0.026
Remote heart rate variability biofeedback is an effective intervention for decreasing depressive symptoms and increasing HRV across various populations, though it did not significantly reduce perceived stress.
Remote HRV-B reduces depressive symptoms and boosts HRV; extends prior evidence to scalable remote delivery for mental health.
Heart rate variability biofeedback (HRV-B) is a technique that has been shown to have benefits for both physical and mental health conditions. The aim of the present systematic review and meta-analysis is to describe the methodological approach and examine the efficacy of remote HRV-B interventions for mental health symptoms, including depression, stress, anxiety, and sleep as well as heart rate variability (HRV), a measure of autonomic function. A systematic literature search was conducted from five databases and eighteen studies with a total of 1352 subjects from different populations were included in this systematic review and meta-analysis based on the inclusion criteria. Meta-analysis showed a medium effect size of HRV-B for improving both depression ( g = − 0.41 [− 0.049, − 0.772], p = 0.026, I 2 = 72.623%, k = 10) and HRV ( g = 0.443, [0.718, 0.167], p = 0.002, I 2 = 56.81%, k = 10) compared to control conditions. These results remained significant after sensitivity analyses excluding high-risk, non-randomized, and outlier studies. Effect for stress was not significant ( p = 0.152, k = 8). Meta-regressions identified study and protocol characteristics as significant moderators of the effect on HRV, stress, and anxiety. Specifically, maximizing resonance, screen on the device, less lab visits, less than twenty minutes of practice time per day, and female gender were beneficial for the intervention effectiveness. Overall, this study indicates that HRV-B is an effective intervention for decreasing depressive symptoms and increasing HRV across populations, and some intervention variables may influence the intervention outcomes.
No takes yet. Share an insight, caveat, or question.
Vann-Adibe et al. (2025) conducted a meta-analysis in Mental health symptoms (depression, stress, anxiety, sleep) (n=1,352). Remote Heart Rate Variability Biofeedback (HRV-B) vs. Control conditions (treatment as usual or waitlist) was evaluated on Depressive symptoms (g = -0.41, 95% CI -0.772 to -0.049, p=0.026). Remote heart rate variability biofeedback significantly improved depressive symptoms (g = -0.41) and heart rate variability (g = 0.443) compared to control conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: